Two promising topical treatments for molluscum contagiosumThis common skin condition has been historically difficult to treat, but new therapies could be first U.S. FDA-approved options. New Product: GermStopSQA new disinfectant promises to kill germs for 24 hours after application—including 99.9% of bacteria and 99.9% of Human Coronavirus 229E. Evusheld 'unlikely to be active' against new COVID-19 subvariants: Health Canada Healthcare professionals should be aware of the drug’s limitations against newer variants—and make sure they communicate them clearly to patients. New study finds fluvoxamine ineffective for mild to moderate COVID-19 in outpatients Although study results have been conflicting, overall evidence does not support use of fluvoxamine for current treatment of mild to moderate COVID-19. Will pharmacy prescribing improve healthcare? Patients (and politicians) will love this. But in my view, patient satisfaction should not be used as a metric to determine any healthcare policy. Ottawa, Kitchener hospitals saw record numbers of patients admitted this week Queensway Carleton Hospital in Ottawa says Tuesday was the busiest day in the hospital's 47-year history, with 361 patients admitted. How should acute COVID-19 be managed in children? Pediatric COVID-19 working group of AMMI Canada issues practice point on the treatment of acute COVID-19 in children. Quebec pharma company creates generic antibiotic to help combat shortages Quebec-based Mantra Pharma has created a generic drug called M-Amoxi Clav, a generic version of the antibiotic Clavulin. 'Kraken' subvariant name beats 'alphabet soup' moniker for XBB.1.5: biologist Ryan Gregory of the University of Guelph dubbed the latest subvariant Kraken, the name of a Scandinavian mythological sea creature. B.C. to reactivate its COVID emergency operations centres to prepare for more illness Health Minister Adrian Dix said Friday they've been coping with an unprecedented increase in demand in the healthcare system. First Previous 110 111 112 113 114 Next Last
